IL151097D0 - Tumour-specific animal proteins - Google Patents

Tumour-specific animal proteins

Info

Publication number
IL151097D0
IL151097D0 IL15109701A IL15109701A IL151097D0 IL 151097 D0 IL151097 D0 IL 151097D0 IL 15109701 A IL15109701 A IL 15109701A IL 15109701 A IL15109701 A IL 15109701A IL 151097 D0 IL151097 D0 IL 151097D0
Authority
IL
Israel
Prior art keywords
tumour
animal proteins
specific animal
specific
proteins
Prior art date
Application number
IL15109701A
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GB0004269A priority Critical patent/GB0004269D0/en
Priority to GB0009905A priority patent/GB0009905D0/en
Priority to GB0021080A priority patent/GB0021080D0/en
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Priority to PCT/EP2001/001779 priority patent/WO2001062778A2/en
Publication of IL151097D0 publication Critical patent/IL151097D0/en

Links

IL15109701A 2000-02-23 2001-02-16 Tumour-specific animal proteins IL151097D0 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
GB0004269A GB0004269D0 (en) 2000-02-23 2000-02-23 Novel compounds
GB0009905A GB0009905D0 (en) 2000-04-20 2000-04-20 Novel compounds
GB0021080A GB0021080D0 (en) 2000-08-25 2000-08-25 Novel compounds
PCT/EP2001/001779 WO2001062778A2 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins

Publications (1)

Publication Number Publication Date
IL151097D0 true IL151097D0 (en) 2003-04-10

Family

ID=27255552

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15109701A IL151097D0 (en) 2000-02-23 2001-02-16 Tumour-specific animal proteins
IL15109702A IL151097A (en) 2000-02-23 2002-08-06 Immunogenic composition comprising a casb7439 polypeptide and its use in the manufacture of a vaccine for treating colon-associated diseases

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL15109702A IL151097A (en) 2000-02-23 2002-08-06 Immunogenic composition comprising a casb7439 polypeptide and its use in the manufacture of a vaccine for treating colon-associated diseases

Country Status (24)

Country Link
US (5) US20030157118A1 (en)
EP (2) EP1650221B1 (en)
JP (1) JP5502253B2 (en)
KR (2) KR20090085697A (en)
CN (1) CN1254541C (en)
AT (1) AT487733T (en)
AU (3) AU2001256156B2 (en)
BR (1) BR0108654A (en)
CA (1) CA2400842C (en)
CY (2) CY1111156T1 (en)
CZ (1) CZ303468B6 (en)
DE (1) DE60143425D1 (en)
DK (2) DK1650221T3 (en)
ES (1) ES2389445T3 (en)
HK (2) HK1093513A1 (en)
HU (1) HU0300054A3 (en)
IL (2) IL151097D0 (en)
MX (1) MXPA02008279A (en)
NO (1) NO332141B1 (en)
NZ (1) NZ520673A (en)
PL (1) PL209127B1 (en)
PT (2) PT1265915E (en)
SI (2) SI1265915T1 (en)
WO (1) WO2001062778A2 (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT534401T (en) * 2000-10-18 2011-12-15 Glaxosmithkline Biolog Sa Mage antigen coupled to a protein d fragment containing vaccines
CZ303468B6 (en) * 2000-02-23 2012-10-03 Smithkline Beecham Biologicals S. A. Immunogenic mixture and pharmaceutical mixture
US8039602B2 (en) 2000-10-31 2011-10-18 Ryogen Llc Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
GB0100756D0 (en) 2001-01-11 2001-02-21 Powderject Res Ltd Needleless syringe
GB0111974D0 (en) * 2001-05-16 2001-07-04 Glaxosmithkline Biolog Sa Novel Compounds
CA2496925A1 (en) * 2002-08-29 2004-03-11 Genentech, Inc. Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
CN1310033C (en) * 2004-03-23 2007-04-11 中国医学科学院肿瘤医院肿瘤研究所 Method for detecting serum protein fingerprint
MX2009012381A (en) 2007-05-24 2009-12-01 Glaxosmithkline Biolog Sa Lyophilised antigen composition.
WO2007140958A2 (en) 2006-06-02 2007-12-13 Glaxosmithkline Biologicals S.A. Method for identifying whether a patient will be responder or not to immunotherapy
GB0708758D0 (en) 2007-05-04 2007-06-13 Powderject Res Ltd Particle cassettes and process thereof
MX2011012623A (en) * 2009-05-27 2011-12-14 Glaxosmithkline Biolog Sa Casb7439 constructs.
GB0917457D0 (en) 2009-10-06 2009-11-18 Glaxosmithkline Biolog Sa Method
US20110129574A1 (en) * 2009-11-30 2011-06-02 Pathak Chandrashekhar P Methods and compositions for filling fleshy fruits and vegetables
US10047116B2 (en) * 2011-10-03 2018-08-14 Mx Adjuvac Ab Nanoparticles, process for preparation and use thereof as carrier for amphipatic and hydrophobic molecules in fields of medicine including cancer treatment and food related compounds
US10422675B2 (en) 2017-06-09 2019-09-24 Aps Technology, Inc. System and method for monitoring mud flow in a component of drilling system

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4372945A (en) 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
US4235877A (en) 1979-06-27 1980-11-25 Merck & Co., Inc. Liposome particle containing viral or bacterial antigenic subunit
IL61904A (en) 1981-01-13 1985-07-31 Yeda Res & Dev Synthetic vaccine against influenza virus infections comprising a synthetic peptide and process for producing same
US4603112A (en) 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4769330A (en) 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
US4436727A (en) 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4866034A (en) 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
GB8508845D0 (en) 1985-04-04 1985-05-09 Hoffmann La Roche Vaccinia dna
US4777127A (en) 1985-09-30 1988-10-11 Labsystems Oy Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US4877611A (en) 1986-04-15 1989-10-31 Ribi Immunochem Research Inc. Vaccine containing tumor antigens and adjuvants
US5811128A (en) 1986-10-24 1998-09-22 Southern Research Institute Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
US5075109A (en) 1986-10-24 1991-12-24 Southern Research Institute Method of potentiating an immune response
GB8702816D0 (en) 1987-02-07 1987-03-11 Al Sumidaie A M K Obtaining retrovirus-containing fraction
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
US4790824A (en) 1987-06-19 1988-12-13 Bioject, Inc. Non-invasive hypodermic injection device
US4897268A (en) 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
DE10399032I1 (en) 1987-08-28 2004-01-29 Health Research Inc Recombinant viruses.
WO1989001973A2 (en) 1987-09-02 1989-03-09 Applied Biotechnology, Inc. Recombinant pox virus for immunization against tumor-associated antigens
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
AP129A (en) 1988-06-03 1991-04-17 Smithkline Biolog Expression of retrovirus gag protein eukaryotic cells
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
US5549910A (en) 1989-03-31 1996-08-27 The Regents Of The University Of California Preparation of liposome and lipid complex compositions
WO1990013361A1 (en) 1989-05-04 1990-11-15 Southern Research Institute Improved encapsulation process and products therefrom
EP0845537A1 (en) 1989-08-18 1998-06-03 Chiron Corporation Recombinant retroviruses delivering vector constructs to target cells
US5725871A (en) 1989-08-18 1998-03-10 Danbiosyst Uk Limited Drug delivery compositions comprising lysophosphoglycerolipid
KR920007887B1 (en) 1989-08-29 1992-09-18 우찌야마 히사오 Exhaust gas cleaning device for internal combustion engine
NZ235315A (en) 1989-09-19 1991-09-25 Wellcome Found Chimaeric hepadnavirus core antigen proteins and their construction
US5707644A (en) 1989-11-04 1998-01-13 Danbiosyst Uk Limited Small particle compositions for intranasal drug delivery
US5064413A (en) 1989-11-09 1991-11-12 Bioject, Inc. Needleless hypodermic injection device
US5312335A (en) 1989-11-09 1994-05-17 Bioject Inc. Needleless hypodermic injection device
DK0500799T3 (en) 1989-11-16 1998-09-14 Univ Duke The particle-mediated transformation of animal tissue cells
FR2658432B1 (en) 1990-02-22 1994-07-01 Medgenix Group Sa Microspheres for the controlled release of water soluble materials and method of preparation.
US5466468A (en) 1990-04-03 1995-11-14 Ciba-Geigy Corporation Parenterally administrable liposome formulation comprising synthetic lipids
SE466259B (en) 1990-05-31 1992-01-20 Arne Forsgren Protein D - an IgD-binding protein FROM Haemophilus influenzae, and anvaendning this Foer analysis, vaccines and uppreningsaendamaal
AU8200191A (en) 1990-07-09 1992-02-04 United States of America, as represented by the Secretary, U.S. Department of Commerce, The High efficiency packaging of mutant adeno-associated virus using amber suppressions
JP3218637B2 (en) 1990-07-26 2001-10-15 大正製薬株式会社 Stable aqueous liposomal suspension
GB2269820B (en) 1990-08-15 1995-03-29 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
JP2958076B2 (en) 1990-08-27 1999-10-06 株式会社ビタミン研究所 Multilamellar liposomes and gene trapped multilamellar liposome preparation, as well as a process for their preparation for gene transfer
GB9022190D0 (en) 1990-10-12 1990-11-28 Perham Richard N Immunogenic material
US5173414A (en) 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
CA2115742A1 (en) 1991-08-20 1993-03-04 Ronald G. Crystal Adenovirus mediated transfer of genes to the gastrointestinal tract
US5756353A (en) 1991-12-17 1998-05-26 The Regents Of The University Of California Expression of cloned genes in the lung by aerosol-and liposome-based delivery
MX9300883A (en) * 1992-02-18 1994-08-31 Smithkline Beecham Corp Polypeptides vaccine.
DE69312487T2 (en) 1992-05-18 1997-11-27 Minnesota Mining & Mfg Means for transmucosal drug delivery
DK0671948T3 (en) 1992-06-25 1997-09-01 Smithkline Beecham Biolog A vaccine composition containing adjuvants
US5383851A (en) 1992-07-24 1995-01-24 Bioject Inc. Needleless hypodermic injection device
DE69418699D1 (en) 1993-01-11 1999-07-01 Dana Farber Cancer Inst Inc Induction of cytotoxic T lymphocyte reply
US5654186A (en) 1993-02-26 1997-08-05 The Picower Institute For Medical Research Blood-borne mesenchymal cells
FR2702160B1 (en) 1993-03-02 1995-06-02 Biovecteurs As Synthetic particulate vector and preparation process.
US5747292A (en) 1993-04-06 1998-05-05 Fred Hutchinson Cancer Research Center Chimeric cytokine receptors in lymphocytes
FR2704145B1 (en) 1993-04-21 1995-07-21 Pasteur Institut particulate and pharmaceutical composition containing the vector.
CA2164623A1 (en) 1993-06-07 1994-12-22 Robert Enrico Pacifici Hybrid receptor molecules
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6015686A (en) 1993-09-15 2000-01-18 Chiron Viagene, Inc. Eukaryotic layered vector initiation systems
EP0679716A4 (en) 1993-11-12 1999-06-09 Kenichi Matsubara Gene signature.
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
AT300609T (en) 1994-01-21 2005-08-15 Powderject Vaccines Inc Gas-operated element for transferring general material
US5792451A (en) 1994-03-02 1998-08-11 Emisphere Technologies, Inc. Oral drug delivery compositions and methods
US5505947A (en) 1994-05-27 1996-04-09 The University Of North Carolina At Chapel Hill Attenuating mutations in Venezuelan Equine Encephalitis virus
WO1996002555A1 (en) 1994-07-15 1996-02-01 The University Of Iowa Research Foundation Immunomodulatory oligonucleotides
FR2723849B1 (en) 1994-08-31 1997-04-11 Biovector Therapeutics Sa Method to increase the immunogenicity, the product obtained and pharmaceutical composition
US5795587A (en) 1995-01-23 1998-08-18 University Of Pittsburgh Stable lipid-comprising drug delivery complexes and methods for their production
GB9502879D0 (en) 1995-02-14 1995-04-05 Oxford Biosciences Ltd Particle delivery
US5580579A (en) 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
CA2217178C (en) 1995-04-25 2009-09-29 Smithkline Beecham Biologicals S.A. Vaccines containing a saponin and a sterol
US5738868A (en) 1995-07-18 1998-04-14 Lipogenics Ltd. Liposome compositions and kits therefor
EP0871747A1 (en) 1996-01-02 1998-10-21 Chiron Viagene, Inc. Immunostimulation mediated by gene-modified dendritic cells
HU0001991A3 (en) * 1996-02-09 2003-08-28 Univ Liege Vaccines against varicella zoster virus gene 63 product
US5776683A (en) 1996-07-11 1998-07-07 California Pacific Medical Center Methods for identifying genes amplified in cancer cells
US5856462A (en) 1996-09-10 1999-01-05 Hybridon Incorporated Oligonucleotides having modified CpG dinucleosides
US5811407A (en) 1997-02-19 1998-09-22 The University Of North Carolina At Chapel Hill System for the in vivo delivery and expression of heterologous genes in the bone marrow
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6355257B1 (en) 1997-05-08 2002-03-12 Corixa Corporation Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US5993412A (en) 1997-05-19 1999-11-30 Bioject, Inc. Injection apparatus
GB9727262D0 (en) 1997-12-24 1998-02-25 Smithkline Beecham Biolog Vaccine
AT505542T (en) * 1998-02-05 2011-04-15 Glaxosmithkline Biolog Sa Tumor associated mortal family antigen derivatives for the preparation of fusion proteins with t-help epitopes and compositions for vaccination
ID26669A (en) 1998-02-12 2001-01-25 Immune Complex Corp Core proteins modified hepatitis B and their derivatives strategy
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
BR9908599A (en) * 1998-03-09 2000-11-14 Smithkline Beecham Biolog combined vaccine compositions
HU0101619A3 (en) 1998-04-09 2003-11-28 Smithkline Beecham Biolog Adjuvant compositions
CA2340174C (en) 1998-08-10 2011-01-04 Aquila Biopharmaceuticals, Inc. Compositions of cpg and saponin adjuvants and methods thereof
US6087168A (en) * 1999-01-20 2000-07-11 Cedars Sinai Medical Center Conversion of non-neuronal cells into neurons: transdifferentiation of epidermal cells
AT342727T (en) * 1999-03-11 2006-11-15 Glaxosmithkline Biolog Sa Use of casb618 polynucleotides and polypeptides
AU5788900A (en) 1999-07-07 2001-01-22 Tularik Inc. Diagnosis of cancer by detecting ash2 polypeptides or polynucleotides
AU3658901A (en) 2000-02-04 2001-08-14 Aeomica Inc Methods and apparatus for high-throughput detection and characterization of alternatively spliced genes
CZ303468B6 (en) * 2000-02-23 2012-10-03 Smithkline Beecham Biologicals S. A. Immunogenic mixture and pharmaceutical mixture
US7811574B2 (en) * 2000-02-23 2010-10-12 Glaxosmithkline Biologicals S.A. Tumour-specific animal proteins
US8039602B2 (en) * 2000-10-31 2011-10-18 Ryogen Llc Isolated genomic polynucleotide fragments from the p15 region of chromosome 11
CA2496925A1 (en) 2002-08-29 2004-03-11 Genentech, Inc. Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
MX2011012623A (en) 2009-05-27 2011-12-14 Glaxosmithkline Biolog Sa Casb7439 constructs.

Also Published As

Publication number Publication date
AU2001256156B2 (en) 2006-01-05
DE60143425D1 (en) 2010-12-23
AU5615601A (en) 2001-09-03
IL151097A (en) 2012-05-31
JP2003530088A (en) 2003-10-14
DK1650221T3 (en) 2012-09-03
US20110052615A1 (en) 2011-03-03
EP1265915B1 (en) 2010-11-10
ES2389445T3 (en) 2012-10-26
US20060171953A1 (en) 2006-08-03
KR100919916B1 (en) 2009-10-07
PL209127B1 (en) 2011-07-29
PT1265915E (en) 2011-02-07
JP5502253B2 (en) 2014-05-28
US20120244175A1 (en) 2012-09-27
NO20024002D0 (en) 2002-08-22
EP1265915A2 (en) 2002-12-18
US20100291121A1 (en) 2010-11-18
HU0300054A2 (en) 2003-05-28
MXPA02008279A (en) 2002-11-29
CZ303468B6 (en) 2012-10-03
US20030157118A1 (en) 2003-08-21
HK1093513A1 (en) 2013-03-15
KR20080029007A (en) 2008-04-02
WO2001062778A3 (en) 2002-04-04
DK1265915T3 (en) 2011-02-14
EP1650221B1 (en) 2012-06-27
US8535690B2 (en) 2013-09-17
NZ520673A (en) 2004-09-24
HU0300054A3 (en) 2012-09-28
AU2006201042A1 (en) 2006-03-30
US7803379B2 (en) 2010-09-28
KR20090085697A (en) 2009-08-07
NO20024002L (en) 2002-10-22
CN1254541C (en) 2006-05-03
EP1650221A2 (en) 2006-04-26
HK1052710A1 (en) 2011-05-13
AU2006201042B2 (en) 2009-10-08
SI1650221T1 (en) 2012-09-28
AT487733T (en) 2010-11-15
CY1113109T1 (en) 2016-04-13
CA2400842A1 (en) 2001-08-30
PL362698A1 (en) 2004-11-02
WO2001062778A2 (en) 2001-08-30
SI1265915T1 (en) 2011-02-28
CZ20022874A3 (en) 2003-02-12
PT1650221E (en) 2012-09-05
US8207123B2 (en) 2012-06-26
CN1426421A (en) 2003-06-25
EP1650221A3 (en) 2006-12-20
CA2400842C (en) 2013-01-15
BR0108654A (en) 2003-04-29
NO332141B1 (en) 2012-07-02
CY1111156T1 (en) 2015-06-11

Similar Documents

Publication Publication Date Title
DK1337157T3 (en) Protein hydrolysates
DE50115624D1 (en) Towing
DK1309861T3 (en) Functional protein arrays
DE50108291D1 (en) Bone nail
DE60124098D1 (en) Modoficated morbillivirus v proteins
DE60037450D1 (en) Funf-helix protein
AU6104001A (en) Motion-tracking
HK1051004A1 (en) Modified factor VIII
AU2784901A (en) Ultrasonic imager
EP1113799A4 (en) Protein formulations
AU7673701A (en) Protein injection preparations
AU9419201A (en) Solid preparations
PT1280401E (en) Extensive for animals
AU5462301A (en) Protein variants having modified immunogenicity
GB0010434D0 (en) Cat flap
GB2370225B (en) Emanator
AU8253501A (en) Pet device
DE60143234D1 (en) Peptide
DE60139763D1 (en) Lanzes and animals
AU6994401A (en) Protein expression profiling
AU3600501A (en) Preparations stabilized over long time
AU3279901A (en) Protein c derivatives
AU9592801A (en) Tractor
AU2963902A (en) Protein arrays
DE50013267D1 (en) Hitch